Diagnosis and treatment of benign focal liver lesions

Scandinavian Journal of Gastroenterology

Volumn 41, Issue SUPPL. 243, 2006, Pages 102-115

  Terkivatan, Türkan ^a   Hussain, Shahid ^a   De Man, Rob ^a   Ijzermans, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Benign tumours; Diagnosis; Liver; Treatment

Indexed keywords

CONTRAST MEDIUM;

CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; INCIDENTAL FINDING; LIVER BIOPSY; LIVER DISEASE; LIVER TUMOR; MEDLINE; PRIORITY JOURNAL; RADIODIAGNOSIS; TISSUE SPECIFICITY; TREATMENT INDICATION; ANGIOMYOLIPOMA; ARTIFICIAL EMBOLISM; CAVERNOUS HEMANGIOMA; HAMARTOMA; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER HYDATID CYST; LIVER RESECTION; NODULAR HYPERPLASIA; REVIEW;

ADENOMA, LIVER CELL; ANGIOMYOLIPOMA; CARCINOMA, HEPATOCELLULAR; ECHINOCOCCOSIS, HEPATIC; EMBOLIZATION, THERAPEUTIC; FOCAL NODULAR HYPERPLASIA; HAMARTOMA; HEMANGIOMA, CAVERNOUS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS;

EID: 33745394615     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600664391     Document Type: Conference Paper

References (144)

1. Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 2000;24:372-6.
2. Terkivatan T, de Wilt JH, De Man RA, van Rijn RR, Zondervan PE, Tilanus HW, et al. Indications and long-term outcome of treatment for benign hepatic tumours: a critical appraisal. Arch Surg 2001;136:1033-8.
3. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995;22:1674-81.
4. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 1995;19:19-24.
5. Chen MF. Hepatic resection for benign tumours of the liver. J Gastroenterol Hepatol 2000;15:587-92.
6. Belghiti J, Pateron D, Panis Y, Vilgrain V, Flejou JF, Benhamou JP, et al. Resection of presumed benign liver tumours. Br J Surg 1993;80:380-3.
7. Shimizu S, Takayama T, Kosuge T, Yamamoto J, Shimada K, Yamazaki S, et al. Benign tumours of the liver resected because of a diagnosis of malignancy. Surg Gynecol Obstet 1992;174:403-7.
8. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin N Am 1975;59:995-1002.
9. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173-8.
10. Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973;2:926-9.
11. Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976;294:470-2.
12. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. J Am Med Assoc 1979;242:644-8.
13. Heinemann LA, Weimann A, Gerken G, Thiel C, Schlaud M, DoMinh T. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998;3:194-200.
14. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997;21:983-90.
15. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995;19:13-8.
16. Kudo M. Hepatocellular adenoma in type Ia glycogen storage disease. J Gastroenterol 2001;36:65-6.
17. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997;24:276-9.
18. Hasan N, Coutts M, Portmann B. Pigmented liver cell adenoma in two male patients. Am J Surg Pathol 2000;24:1429-32.
19. Bagia S, Hewitt PM, Morris DL. Anabolic steroid-induced hepatic adenomas with spontaneous haemorrhage in a bodybuilder. Aust NZ J Surg 2000;70:686-7.
20. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001;25:1388-96.
21. Aseni P, Sansalone CV, Sammartino C, Benedetto FD, Carrafiello G, Giacomoni A, et al. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol 2001;33:234-6.
22. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400.
23. Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 1996;62:825-9.
24. Terkivatan T, de Wilt JH, De Man RA, van Rijn RR, Tilanus HW, IJzermans JN. Treatment of ruptured hepatocellular adenoma. Br J Surg 2001;88:207-9.
25. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991;173:426-31.
26. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994;129:712-7.
27. Tao LC. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation. Cancer 1991;68:341-7.
28. Klatskin G, Conn HO. Histopathology of the liver. New York: Oxford University Press; 1993. p 368.
29. Ruschenburg I, Hofmann M, Diab E, Droese M. Comparison of the DNA content in liver cell adenoma, hepatocellular carcinoma and regenerative nodules. Anticancer Res 2000;20:1861-4.
30. Wilkens L, Bredt M, Flemming P, Becker T, Klempnauer J, Kreipe HH. Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol 2001;193:476-82.
31. Wilkens L, Bredt M, Flemming P, Schwarze Y, Becker T, Mengel M, et al. Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Mol Diagn 2001;3:68-73.
32. Ruppert-Kohlmayr AJ, Uggowitzer MM, Kugler C, Zebedin D, Schaffler G, Ruppert GS. Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT. Am J Roentgenol 2001;176:1493-8.
33. Motohara T, Semelka RC, Nagase L. MR imaging of benign hepatic tumors. Magn Reson Imaging Clin N Am 2002;10:1-14.
34. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic adenoma: MR characteristics and correlation with pathologic findings. Am J Roentgenol 1994;163:113-6.
35. Martin DR, Semelka RC, Chung JJ, Balci NC, Wilber K. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations. Magn Reson Imaging 2000;18:955-63.
36. Paley MR, Mergo PJ, Torres GM, Ros PR. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. Am J Roentgenol 2000;175:159-63.
37. Kume N, Suga K, Nishigauchi K, Shimizu K, Matsunaga N. Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging. Clin Nucl Med 1997;22:825-31.
38. Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am 1998;36:319-31.
39. Lubbers PR, Ros PR, Goodman ZD, Ishak KG. Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation. Am J Roentgenol 1987;148:1105-8.
40. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y, et al. Management of 155 patients with benign liver tumours. Br J Surg 2001;88:808-13.
41. Terkivatan T, de Wilt JH, De Man RA, IJzermans JN. Management of hepatocellular adenoma during pregnancy. Liver 2000;20:186-7.
42. Hill MA, Albert T, Zieske A, Levine EA. Successful resection of multifocal hepatic adenoma during pregnancy. South Med J 1997;90:357-61.
43. Gianopoulos JG. Establishing the criteria for anesthesia and other precautions for surgery during pregnancy. Surg Clin North Am 1995;75:33-45.
44. Luciani A, Kobeiter H, Maison P, Cherqui D, Zafrani ES, Dhumeaux D, et al. Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut 2002;50:877-80.
45. Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis 2001;5:17-42.
46. Pain JA, Gimson AE, Williams R, Howard ER. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 1991;32:524-7.
47. Sadowski DC, Lee SS, Wanless IR, Kelly JK, Heathcote EJ. Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology 1995;21:970-5.
48. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-200.
49. Gaffey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996;148:1089-96.
50. Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000;118:560-4.
51. Benz EJ, Baggenstoss AH. Focal cirrhosis of the liver in relation to the so-called hamartoma (adenoma, benign hepatoma). Cancer 1953;6:743-55.
52. Fechner ER. Benign hepatic lesions and orally administered contraceptives. Hum Pathol 1977;8:255-68.
53. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-54.
54. Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, IJzermans JN, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004;24:3-17.
55. Di Stasi M, Caturelli E, De SI, Salmi A, Buscarini E, Buscarini L. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound 1996;24:345-50.
56. Kehagias D, Moulopoulos L, Antoniou A, Hatziioannou A, Smyrniotis V, Trakadas S, et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 2001;11:202-12.
57. Brancatelli G, Federle MP, Grazioli L, Blachar A, Peterson MS, Thaete L. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001;219:61-8.
58. Carlson SK, Johnson CD, Bender CE, Welch TJ. CT of focal nodular hyperplasia of the liver. Am J Roentgenol 2000;174:705-12.
59. Buetow PC, Pantongrag-Brown L, Buck JL, Ros PR, Goodman ZD. Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics 1996;16:369-88.
60. McLarney JK, Rucker PT, Bender GN, Goodman ZD, Kashitani N, Ros PR. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics 1999;19:453-71.
61. Marti-Bonmati L, Casillas C, Dosda R. Enhancement characteristics of hepatic focal nodular hyperplasia and its scar by dynamic magnetic resonance imaging. MAGMA 2000;10:200-4.
62. Martin DR, Semelka RC. Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 2001;9:785-802.
63. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401.
64. Boulahdour H, Cherqui D, Charlotte F, Rahmouni A, Dhumeaux D, Zafrani ES, et al. The hot spot hepatobiliary scan in focal nodular hyperplasia. J Nucl Med 1993;34:2105-10.
65. Weimann A, Mossinger M, Fronhoff K, Nadalin S, Raab R. Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet 1998;351:1251-2.
66. Deutsch GS, Yeh KA, Bates WB III, Tannehill WB. Embolization for management of hepatic hemangiomas. Am Surg 2001;67:159-64.
67. Saccheri S, Lovaria A, Sangiovanni A, Nicolini A, De Fazio C, Ronchi G, et al. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. J Vasc Interv Radiol 2002;13:995-9.
68. Bassel K, Lee M, Seymour NE. Focal nodular hyperplasia of the liver. South Med J 1994;87:918-20.
69. De Carlis L, Pirotta V, Rondinara GF, Sansalone CV, Colella G, Maione G, et al. Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 1997;3:160-5.
70. Terkivatan T, Hussain SM, Lameris JS, IJzermans JN. Transcatheter arterial embolization as a safe and effective treatment for focal nodular hyperplasia of the liver. Cardiovasc Intervent Radiol 2002;25:450-3.
71. Bender BL, Yunis EJ. The pathology of tuberous sclerosis. Pathol Annu 1982;17:339-82.
72. Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review. J Gastroenterol 1994;29:95-105.
73. Brunt EM. Benign tumors of the liver. Clin Liver Dis 2001;5:1-15.
74. Sawai H, Manabe T, Yamanaka Y, Kurahashi S, Kamiya A. Angiomyolipoma of the liver: case report and collective review of cases diagnosed from fine needle aspiration biopsy specimens. J Hepato Pancreat Surg 1998;5:333-8.
75. Ahmadi T, Itai Y, Takahashi M, Onaya H, Kobayashi T, Tanaka YO, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging 1998;23:520-6.
76. Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol 1999;23:34-48.
77. Caremani M, Vincenti A, Benci A, Sassoli S, Tacconi D. Ecographic epidemiology of non-parasitic hepatic cysts. J Clin Ultrasound 1993;21:115-8.
78. Regev A, Reddy KR, Berho M, Sleeman D, Levi JU, Livingstone AS, et al. Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center. J Am Coll Surg 2001;193:36-45.
79. Doty JE, Tompkins RK. Management of cystic disease of the liver. Surg Clin North Am 1989;69:285-95.
80. Lai EC, Wong J. Symptomatic nonparasitic cysts of the liver. World J Surg 1990;14:452-6.
81. Pliskin A, Cualing H, Stenger RJ. Primary squamous cell carcinoma originating in congenital cysts of the liver. Report of a case and review of the literature. Arch Pathol Lab Med 1992;116:105-7.
82. Clouse ME. Current diagnostic imaging modalities of the liver. Surg Clin North Am 1989;69:193-234.
83. Mathieu D, Vilgrain V, Mahfouz AE, Anglade MC, Vullierme MP, Denys A. Benign liver tumors. Magn Reson Imaging Clin N Am 1997;5:255-88.
84. Mortele KJ, Ros PR. Benign liver neoplasms. Clin Liver Dis 2002;6:119-45.
85. Moorthy K, Mihssin N, Houghton PW. The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 2001;83:409-14.
86. Klingler PJ, Gadenstatter M, Schmid T, Bodner E, Schwelberger HG. Treatment of hepatic cysts in the era of laparoscopic surgery. Br J Surg 1997;84:438-44.
87. Karavias DD, Tsamandas AC, Payatakes AH, Solomou E, Salakou S, Felekouras ES, et al. Simple (non-parasitic) liver cysts: clinical presentation and outcome. Hepatogastroenterology 2000;47:1439-43.
88. Florman SS, Slakey DP. Giant biliary cystadenoma: case report and literature review. Am Surg 2001;67:727-32.
89. Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 1977;39:322-38.
90. Subramony C, Herrera GA, Turbat-Herrera EA. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis. Arch Pathol Lab Med 1993;117:1036-42.
91. Knott AW, Ampudia RJ, Evankovich C, Teplick SK, Herrera JL, Tucker JA Jr, et al. Biliary cystadenoma: rare variant of intrahepatic cystic disease. South Med J 2000;93:698-702.
92. Lauffer JM, Baer HU, Maurer CA, Stoupis C, Zimmerman A, Buchler MW. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998;34:1845-51.
93. D'Errico A, Deleonardi G, Fiorentino M, Scoazec JY, Grigioni WF. Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma. Diagn Mol Pathol 1998;7:289-94.
94. Buetow PC, Buck JL, Pantongrag-Brown L, Ros PR, Devaney K, Goodman ZD, et al. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 1995;196:805-10.
95. Mortele KJ, Ros PR. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 2001;21:895-910.
96. Stoupis C, Ros PR, Dolson DJ. Recurrent biliary cystadenoma: MR imaging appearance. J Magn Reson Imaging 1994;4:99-101.
97. Hansman MF, Ryan JA Jr, Holmes JH, Hogan S, Lee FT, Kramer D, et al. Management and long-term follow-up of hepatic cysts. Am J Surg 2001;181:404-10.
98. Wei SC, Huang GT, Chen CH, Sheu JC, Tsang YM, Hsu HC, et al. Bile duct hamartomas. A report of two cases. J Clin Gastroenterol 1997;25:608-11.
99. Semelka RC, Hussain SM, Marcos HB, Woosley JT. Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging 1999;10:196-201.
100. Desmet VJ. Ludwig symposium on biliary disorders. Part I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998;73:80-9.
101. Lev-Toaff AS, Bach AM, Wechsler RJ, Hilpert PL, Gatalica Z, Rubin R. The radiologic and pathologic spectrum of biliary hamartomas. Am J Roentgenol 1995;165:309-13.
102. Iqbal N, Saleem A. Hepatic hemangioma: a review. Tex Med 1997;93:48-50.
103. Saegusa T, Ito K, Oba N, Matsuda M, Kojima K, Tohyama K, et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 1995;34:207-11.
104. Spitzer D, Krainz R, Graf AH, Menzel C, Staudach A. Pregnancy after ovarian stimulation and intrauterine insemination in a woman with cavernous macrohemangioma of the liver. A case report. J Reprod Med 1997;42:809-12.
105. Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut 2004;53:1352-5.
106. Adams YG, Huves AG, Fortner JG. Giant hemangiomas of the liver. Ann Surg 1970;172:239-45.
107. Corigliano N, Mercantini P, Amodio PM, Balducci G, Caterino S, Ramacciato G, et al. Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: report of a case. Surg Today 2003;33:459-63.
108. Hotokezaka M, Kojima M, Nakamura K, Hidaka H, Nakano Y, Tsuneyoshi M, et al. Traumatic rupture of hepatic hemangioma. J Clin Gastroenterol 1996;23:69-71.
109. Shimizu M, Miura J, Itoh H, Saitoh Y. Hepatic giant cavernous hemangioma with microangiopathic hemolytic anemia and consumption coagulopathy. Am J Gastroenterol 1990;85:1411-3.
110. Berliner L, el Ferzli G, Gianvito L, Worth MH Jr, Lowry J, Redmond P, et al. Giant cavernous hemangioma of the liver complicated by abscess and thrombosis. Am J Gastroenterol 1983;78:835-40.
111. Nisenbaum HL, Rowling SE. Ultrasound of focal hepatic lesions. Semin Roentgenol 1995;30:324-46.
112. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997;203:121-5.
113. Quinn SF, Benjamin GG. Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 1992;182:545-8.
114. Leslie DF, Johnson CD, Johnson CM, Ilstrup DM, Harmsen WS. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. Am J Roentgenol 1995;164:625-9.
115. Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994;192:401-6.
116. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997;204:739-44.
117. el Desouki M, Mohamadiyeh M, al Rashed R, Othman S, al Mofleh I. Features of hepatic cavernous hemangioma on planar and SPECT Tc-99m-labeled red blood cell scintigraphy. Clin Nucl Med 1999;24:583-9.
118. Landor M, Petrozzo P. Images in clinical medicine. Hepatic hemangioma. N Engl J Med 2000;342:791.
119. Middleton ML. Scintigraphic evaluation of hepatic mass lesions: emphasis on hemangioma detection. Semin Nucl Med 1996;26:4-15.
120. Terkivatan T, Vrijland WW, Den Hoed PT, De Man RA, Hussain SM, Tilanus HW, et al. Size of lesion is not a criterion for resection during management of giant liver haemangioma. Br J Surg 2002;89:1240-4.
121. Leifer DM, Middleton WD, Teefey SA, Menias CO, Leahy JR. Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology 2000;214:167-72.
122. Pietrabissa A, Giulianotti P, Campatelli A, Di Candio G, Farina F, Signori S, et al. Management and follow-up of 78 giant haemangiomas of the liver. Br J Surg 1996;83:915-8.
123. Finch MD, Crosbie JL, Currie E, Garden OJ. An 8-year experience of hepatic resection: indications and outcome. Br J Surg 1998;85:315-9.
124. Hanazaki K, Kajikawa S, Matsushita A, Monma T, Koide N, Nimura Y, et al. Risk factors associated with intra-operative blood loss in hepatectomized patients with giant cavernous hemangioma of the liver. Hepatogastroenterology 1999;46:1089-93.
125. Moreno EA, Del Pozo RM, Vicente CM, Abellan AJ. Indications for surgery in the treatment of hepatic hemangioma. Hepatogastroenterology 1996;43:422-6.
126. Gedaly R, Pomposelli JJ, Pomfret EA, Lewis WD, Jenkins RL. Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg 1999;134:407-11.
127. Baer HU, Dennison AR, Mouton W, Stain SC, Zimmermann A, Blumgart LH. Enucleation of giant hemangiomas of the liver. Technical and pathologic aspects of a neglected procedure. Ann Surg 1992;216:673-6.
128. Althaus S, Ashdown B, Coldwell D, Helton WS, Freeny PC. Transcatheter arterial embolization of two symptomatic giant cavernous hemangiomas of the liver. Cardiovasc Intervent Radiol 1996;19:364-7.
129. Suzuki H, Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M, et al. Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy. Am J Gastroenterol 1997;92:688-91.
130. Russo MW, Johnson MW, Fair JH, Brown RS Jr. Orthotopic liver transplantation for giant hepatic hemangioma. Am J Gastroenterol 1997;92:1940-1.
131. Chui AK, Vass J, McCaughan GW, Sheil AG. Giant cavernous haemangioma: a rare indication for liver transplantation. Aust NZ J Surg 1996;66:122-4.
132. Nishida O, Satoh N, Alam AS, Uchino J. The effect of hepatic artery ligation for irresectable cavernous hemangioma of the liver. Am Surg 1988;54:483-6.
133. Gaspar L, Mascarenhas F, da Costa MS, Dias JS, Afonso JG, Silvestre ME. Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiother Oncol 1993;29:45-50.
134. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999;210:71-4.
135. Torzilli G, Makuuchi M, Ferrero A, Takayama T, Hui AM, Abe H, et al. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. Hepatogastroenterology 2002;49:740-5.
136. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2002;10:31-52.
137. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, De Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002;22:1023-36.
138. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001;218:27-38.
139. Helmberger T, Semelka RC. New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 2001;9:745-66.
140. Franca AV, Valerio HM, Trevisan M, Escanhoela C, Seva-Pereira T, Zucoloto S, et al. Fine needle aspiration biopsy for improving the diagnostic accuracy of cut needle biopsy of focal liver lesions. Acta Cytol 2003;47:332-6.
141. Jain D. Diagnosis of hepatocellular carcinoma: fine needle aspiration cytology or needle core biopsy. J Clin Gastroenterol 2002;35:S101-8.
142. Yu SC, Liew CT, Lau WY, Leung TW, Metreweli C. US-guided percutaneous biopsy of small (
143. tenBerge J, Hoffman BJ, Hawes RH, Van Enckevort C, Giovannini M, Erickson RA, et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 2002;55:859-62.
144. Jourdan JL, Stubbs RS. Percutaneous biopsy of operable liver lesions: is it necessary or advisable? NZ Med J 1996;109:469-70.